Related Experiment Video
Updated: Jun 19, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
[Composite phytoadaptogens in oncology and gerontology]
Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
|October 6, 2009
Summary
Phytomix-40, a plant adaptogen mixture, shows potential in preclinical and clinical studies for treating non-malignant tumors, precancer, advanced cancer, and neurodegenerative diseases.
Area of Science:
- Phytochemistry and Pharmacology
- Immunology
- Oncology
- Neuroscience
Context:
- Research into plant-based adaptogens for therapeutic applications is growing.
- Phytomix-40 is a novel mixture of plant adaptogens.
- Understanding the immunobiological criteria for adaptogen formulation is crucial.
Purpose:
- To evaluate the efficacy and safety of Phytomix-40.
- To investigate its effects on various conditions including benign prostatic hyperplasia, oral leukoplakia, gastric cancer, and parkinsonism.
- To explore its potential in cancer prevention and life extension.
Summary:
- The study details the formulation, manufacturing, and standardization of Phytomix-40.
- Preclinical in vitro and in vivo studies, followed by clinical trials, were conducted.
- Results were assessed in patients with non-malignant tumors, precancer, advanced cancer, and neurodegenerative diseases.
Impact:
- Phytomix-40 demonstrates potential as a non-toxic therapeutic agent.
- Findings suggest prospects for developing new plant-based treatments for cancer and age-related diseases.
- The research contributes to the understanding of adaptogens in disease management and life span extension.
Related Concept Videos
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...